How Common Are Gluten-Related Disorders? The Numbers Tell the Story

Gluten-related disorders, such as celiac disease and non-celiac gluten sensitivity, affect millions of people worldwide, with many cases remaining undiagnosed. These conditions can trigger serious autoimmune damage and long-term health complications, highlighting the need for increased awareness and innovation in the medical and agricultural fields.

In the United States, celiac disease (CeD) is estimated to affect about 1% of the population, or roughly 1 in 133 people. A large screening study conducted in the U.S. found a prevalence of 0.71% (1 in 141) among individuals aged six and older. Among non-Hispanic Caucasians, the rate was slightly higher, at about 1.01%. Globally, serologic studies suggest that around 1.4% of people have celiac disease, while biopsy-confirmed estimates are closer to 0.7%.

Despite these prevalence rates, a significant number of cases remain undiagnosed. Up to 80% or more of people with celiac disease may be undiagnosed or misdiagnosed, a phenomenon often referred to as the "celiac iceberg." This means that many individuals with the condition go untreated for years, potentially leading to severe health complications.

Non-celiac gluten sensitivity (NCGS) is another gluten-related disorder that may be even more widespread. Estimates for NCGS vary widely, ranging from around 1% to as high as 13% of the population. Some reviews suggest that up to 6% of Americans may have non-celiac gluten sensitivity. Unlike celiac disease, NCGS does not involve an autoimmune response to gluten, but it can still cause gastrointestinal symptoms and other health issues.

The health implications of celiac disease are significant. Ingesting gluten in people with the condition triggers an autoimmune reaction that damages the small intestine, leading to nutrient malabsorption, anemia, bone loss, infertility or reduced fertility, and other autoimmune disorders. Diagnosis delays are common, with many individuals waiting 6-10 years to receive a correct diagnosis.

The incidence of diagnosed celiac disease has been increasing in recent years. For example, one study found a pediatric incidence of 21.3 per 100,000 person-years, compared to 12.9 per 100,000 for adults, with an annual increase of approximately 7.5%. This rising trend underscores the need for better diagnostic tools and increased awareness of gluten-related disorders.

As the prevalence and impact of gluten-related disorders become more recognized, innovations such as edited wheat lines developed at UC Davis take on additional relevance for health, agriculture, and food-system stakeholders. These advancements aim to reduce the amount of gluten in wheat, potentially offering relief for individuals with gluten sensitivities while still providing a staple food source.

In conclusion, gluten-related disorders are more common than many people realize, with celiac disease affecting approximately 1% of the global population and non-celiac gluten sensitivity potentially affecting even more individuals. The severity of the health complications associated with these conditions, combined with the challenges of diagnosis and the increasing incidence of diagnosed cases, highlights the need for continued research, improved diagnostic methods, and innovative solutions to address the growing demand for gluten-free alternatives.